Gandhi, Sonia <br/><br/>
Aliskiren improves insulin resistance and ameliorates diabetic renal vascular complications in STZ-induced diabetic rats.  [electronic resource] 

 -  Journal of the renin-angiotensin-aldosterone system : JRAAS  Mar 2013 
 - 3-13 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1752-8976 
<br/><br/><label>Standard No.: </label>10.1177/1470320312452766  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Amides--administration & dosage<br/>Animals<br/>Biomarkers--metabolism<br/>Blood Glucose--metabolism<br/>Body Weight--drug effects<br/>DNA Fragmentation--drug effects<br/>Diabetes Mellitus, Experimental--blood<br/>Diabetic Angiopathies--blood<br/>Diabetic Nephropathies--blood<br/>Extracellular Matrix--drug effects<br/>Fumarates--administration & dosage<br/>Glomerular Filtration Rate--drug effects<br/>Glucose Transporter Type 2--metabolism<br/>Glucose Transporter Type 4--metabolism<br/>Hemodynamics--drug effects<br/>Humans<br/>Inflammation--pathology<br/>Insulin--blood<br/>Insulin Resistance<br/>Liver--drug effects<br/>Mice<br/>Muscles--drug effects<br/>ROC Curve<br/>Rats<br/>Rats, Wistar